ALK Inhibitors for Acquired Resistance: Zykadia and Alectinib

ALK Inhibitors for Acquired Resistance: Zykadia and Alectinib

Da: GRACEcast
0 0 4 anni fa
Dr. Nathan Pennell, Cleveland Clinic, discusses acquired resistance to Xalkori in ALK-positive patients, and second generation inhibitors designed to overcome that resistance, such as Zykadia and alectinib.

Seguici su Facebook